Skrzypczyk, P.; Okarska-Napierała, M.; Pietrzak, R.; Pawlik, K.; Waścińska, K.; Werner, B.; Pańczyk-Tomaszewska, M.
NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease. J. Clin. Med. 2021, 10, 4344.
https://doi.org/10.3390/jcm10194344
AMA Style
Skrzypczyk P, Okarska-Napierała M, Pietrzak R, Pawlik K, Waścińska K, Werner B, Pańczyk-Tomaszewska M.
NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease. Journal of Clinical Medicine. 2021; 10(19):4344.
https://doi.org/10.3390/jcm10194344
Chicago/Turabian Style
Skrzypczyk, Piotr, Magdalena Okarska-Napierała, Radosław Pietrzak, Katarzyna Pawlik, Katarzyna Waścińska, Bożena Werner, and Małgorzata Pańczyk-Tomaszewska.
2021. "NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease" Journal of Clinical Medicine 10, no. 19: 4344.
https://doi.org/10.3390/jcm10194344
APA Style
Skrzypczyk, P., Okarska-Napierała, M., Pietrzak, R., Pawlik, K., Waścińska, K., Werner, B., & Pańczyk-Tomaszewska, M.
(2021). NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease. Journal of Clinical Medicine, 10(19), 4344.
https://doi.org/10.3390/jcm10194344